top of page

Home
Science
Team
Partners
Contacts
More

Use tab to navigate through the menu items.

Address

Via Olgettina 60

20132, Milano

Italy

Contact

info@reprontherapeutics.com

Contact Us

Name

Email

Object

Message

Your message has been sent!

Scientific Strategy

At Repron Therapeutics we are developing first-in-class epigenetic silencers for repressing the transcriptional network of the most cancerous oncogenes. We have developed an innovative strategy to inhibit the activity of oncogenes at the basis of tumor malignancy through the usage of engineered synthetic factors.

Selected Publication

A SOX2-engineered epigenetic silencer factor represses the glioblastoma genetic program and restrains tumor development - Science Advances - 2022

info@reprontherapeutics.com

©2023 by Repron Therapeutics

bottom of page